Australian Orthopedic Association National Registry 2011

The cumulative percent revision at ten years for primary total resurfacing
hip replacement undertaken for osteoarthritis is 7.5%

There are six prostheses with over 1,000 observed component years, the ASR,
Adept, BHR, Cormet, Durom and Mitch TRH. At seven years, the BHR has the lowest
cumulative percent revision (5.0%) compared to Cormet (11.1%), Durom (9.6%) and
ASR (13.0%). The BHR is the only resurfacing prosthesis with a cumulative
percent revision at ten years (6.3%).

Info from the hip resurfacing meetings attended by Patricia Walter in 2011 below:

McMinn/Treacy series

McMinn/Treacy series at 10 years – BHR
survivorship is 99.74%

Mr McMinn’s results with the BHR show a 97%
survival in men and women of all ages at 14.5 years as reported by McMinn’s
website

The Oswestry Registry

The Oswestry Registry reports at 5-8 years for 58 surgeons in 8 countries (not
including McMinn/Treacy)  for 679 hips is 95.7% at 8 years.

The Swedish Registry

The Swedish Registry 2008 reports at 7 years
BHR survivorship all ages is over 98.8%

Canadian Joint Registry

Canadian Joint Registry shows the incidence of hip resurfacing in Canada to
be 3.5% of all captured hip replacement operations in 2010.  This compares to
7.6% for the Australian Registry and 7% for the National Joint Registry in the
UK.  Data on 2790 hip resurfacings from the Canadian Hip Resurfacing workgroup
from 2002 to 2008 showed an overall 5 year survivorship of 96%.  For men under
the age of 65 with a diagnosis of osteoarthritis the five year survivorship was
97.5%.  the five year survivorship for women was 93.7%.  The incidence of
pseudotumors was 0.09% (3/3400)